Trovagene (TROV) Misses Q3 EPS by 1c

November 9, 2016 5:10 PM EST
Get Alerts TROV Hot Sheet
Trade TROV Now!
Join SI Premium – FREE

Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.

Trovagene (NASDAQ: TROV) reported Q3 EPS of ($0.34), $0.01 worse than the analyst estimate of ($0.33). Revenue for the quarter came in at $89 thousand versus the consensus estimate of $320 thousand.

For earnings history and earnings-related data on Trovagene (TROV) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment